HISTORY
2021
Mar 2021 – Selected for KISTA IP-R&D support business for R&D strategy
Apr 2021 – Patent registration - ‘Isolation method of progenitor cells using cold shock and method for producing exosome using these progenitor cells’
May 2021 - Signed MOU with KOLMAR KOREA HOLDINGS for research collaboration using ExDLL platform
May 2021 - Patent registration - 'Pharmaceutical composition for the prevention and treatment of dermatitis using progenitor cell derived multifunctional exosomes
2020
Jan 2020 – Acquired permission for manufacturer and marketing authorization holder from KFDA
Mar 2020 – Acquired permission for LMO (Living Modified Organism) research facility from KCDC
Apr 2020 – Completed toxicity test for TEXsome (Own developed exosome)
May 2020 – Acquired VENTURE COMPANY certification by Ministry of SMEs and Startups
May 2020 – TEXsome acquired approval for INCI application and published in ICID
Jun 2020 – Attend 2020 BIO USA (BIO DIGITAL) (Supported by KOTRA)
Jun 2020 – Completed licensing for cell line establishment
Aug 2020 – Cosmetic manufacturer approved by KFDA
Oct 2020 – Launched cosmetic products ATO STANDARD
2019
Mar 2019 – TIMEBIO Co., Ltd. was founded
Apr 2019 – Established corporate research institute (Certified by Korea Industrial Technology Association)
Jul 2019 – Completed clean room construction and class validation
Nov 2019 – Research using human source granted IRB (Institutional Review Board) approval
Nov 2019 – Signed a 10-year supply contract (exclusive in South Korea) for ATO STANDARD with THERAGEN ETEX Co., Ltd.